Electrocardiography in the diagnosis of arrhythmogenic right ventricular cardiomyopathy
Article Sidebar
Main Article Content
Abstract
The aim of the study was to determine the possibilities of practical application of electrocardiography (ECG) in the diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) according to the analysis of scientific publications over the past five years in journals indexed by Scopus, Web of Science and PubMed. Analysis has shown that ECG plays an increasingly important role in the diagnosis of ARVD/C. The presence of ECG changes characteristic of the disease (epsilon wave, T wave inversions, QRS complex prolongation in leads aVR and V1) allows diagnosis of ARVD/C in half of the cases without the use of ultrasound and tomography techniques. Electrophysiological disturbances in ARVD/C are registered long before the structural ones. This determines the high value of the ECG for early diagnosis of the disease. The methods of ECG analysis developed in recent years greatly expanded the possibilities of the method in differential diagnosis and prediction of the ARVD/C. The popularization of ECG-methods in diagnosis of ARVD/C among general practitioners is necessary to improve the early detection of such a dangerous disease.
Article Details
Keywords:
References
Abidov A, Kannan A, Marcus FI. Definition, Clinical Features, and Classification of ARVC/D. Task Force Criteria for ARVC/D. Cardiac MRI in Diagnosis, Clinical Management, and Prognosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia.2016:35–51.
Akdis D., Brunckhorst C., Duru F, Saguner AM. Arrhythmogenic cardiomyopathy: electrical and structural phenotypes. Arrhythmia & Electrophysiology Review. 2016;5(2):90–101.
Andrews CM, Srinivasan NT, Rosmini S, Bulluck H, Orini M, Jenkins S, Pantazis A, McKenna WJ, Moon JC, Lambiase PD, Rudy Y. Electric and Structural Substrate of Arrhythmogenic Right Ventricular Cardiomyopathy Determined Using Noninvasive Electrocardiographic Imaging and Late Gadolinium MRI. Circulation. 2017;136(9):871–876.
Batchvarov VN, Bastiaenen R, Postema PG, Clark EN, Macfarlane PW, Wilde AA, Behr ER. Novel electrocardiographic criteria for the diagnosis of arrhythmogenic right ventricular cardiomyopathy. Europace. 2016;18(9):1420–1426.
Bhonsale A, Te Riele ASJM, Sawant AC, Groeneweg JA, James CA, Murray B, Tichnell C, Mast TP, van der Pols MJ, Cramer MJM, Dooijes D, van der Heijden JF, Tandri H, van Tintelen JP, Judge DP, Hauer RNW, Calkins H. Cardiac phenotype and long-term prognosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia patients with late presentation. Heart rhythm. 2017;14(6):883–891.
Biernacka EK, Platonov PG, Fronczak A. Should epsilon wave be considered as a major diagnostic criterion in arrhythmogenic right ventricular cardiomyopathy? Kardiologia Polska (Polish Heart J.). 2017;75(3):191–195.
Biernacka KE, Kukla P, Dubowski K, Woźniak O. Early repolarization in patients with arrhythmogenic right ventricular cardiomyopathy is not frequent phenomenon. Intern. J. Cardiology. 2016; 222:982–983.
Brosnan MJ, Te Riele AS, Tichnell C, Murray B. Tandri H, Bosman P, Hoortntje ET, Van Den Berg MP, Van Tintelen JP, Prior DL, Calkins HG, La Gerche A, James C. J-point elevation in subjects with TWI V1-V4 does not differentiate between arrhythmogenic right ventricular cardiomyopathy (ARVC) and healthy athletes when matched for age, sex and ethnicity. Eur. Heart J. 2017;38(Suppl. 1):55.
Calkins H, Corrado D, Marcus F. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy. Circulation. 2017;136(21):2068–2082.
Chan CS, Lin YJ, Chang SL, Lo LW, Hu YF, Chao TF, Chung FP, Liao JN, Chen YJ, Chen SA. Early repolarization of surface ECG predicts fatal ventricular arrhythmias in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy and symptomatic ventricular arrhythmias. Intern. J. Сardiology. 2015;197:300–305.
Chivulescu M, Haugaa K, Lie ØH, Edvardsen T, Ginghină C , Popescu BA, Jurcut R. Right ventricular remodeling in athletes and in arrhythmogenic cardiomyopathy. Scandin. Cardiovasc. J. 2018;52(1):13–19.
Chrispin J, Assis F, Tandri H. Mapping the Electrical Substrate in Arrhythmogenic Right Ventricular Cardiomyopathy: There Is More Than Meets the Eye. Circulation. Arrhythmia and Electrophysiology. 2017;10(7):e005524.
Corrado D, Link MS, Calkins H. Arrhythmogenic right ventricular cardiomyopathy. New Engl. J. Medicine. 2017;376(1):61–72.
Corrado D, Wichter T, Link MS, Hauer RN, Marchlinski FE, Anastasakis A, Bauce B, Basso C, Brunckhorst C, Tsatsopoulou A, Tandri H, Paul M, Schmied C, Pelliccia A, Duru F, Protonotarios N, Estes NM, McKenna WJ, Thiene G, Marcus FI, Calkins H. Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia. An International Task Force Consensus Statement. Circulation. 2015;132:441–453.
Cortez D, Svensson A, Carlson J, Graw S, Sharma N, Brun F, Spezzacatene A, Mestroni L, Platonov PG. Right precordial-directed electrocardiographical markers identify arrhythmogenic right ventricular cardiomyopathy in the absence of conventional depolarization or repolarization abnormalities. BMC Cardiovascular Disorders. 2017;17(1):261–270.
Finocchiaro G, Papadakis M, Dhutia H, Zaidi A, Malhotra A, Fabi E, Cappelletto C, Brook J, Papatheodorou E, Ensam B, Miles CJ, Bastiaenen R, Attard V, Homfray T, Sharma R, Tome M, Carr-White G, Merlo M, Behr ER, Sinagra G, Sharma S. Electrocardiographic diifferentiation between benign T wave inversion and arrhythmogenic right ventricular cardiomyopathy. Eur. Heart J. 2017;38(Suppl. 1):342–343.
Fontaine GH, Duthoit G, Li G, Andreoletti L, Gandjbakhch E, Frank R. Epsilon wave on an electronic loop in a case of arrhythmogenic right ventricular dysplasia with myocarditis: an updated definition of the Epsilon wave. Ep. Europace. 2017;19(7):1084–1090.
Gaido L, Battaglia A, Matta M, Giustetto C, Frea S, Imazio M, Richiardi E, Garberoglio L, Gaita F. Phenotypic expression of ARVC: How 12 lead ECG can predict left or right ventricle involvement. A familiar case series and a review of literature. Intern. J. Сardiology. 2017;236:328–334.
Gallo C, Blandino A, Giustetto C, Anselmino M, Castagno D, Richiardi E, Gaita F. Arrhythmogenic right ventricular cardiomyopathy: ECG progression over time and correlation with long-term follow-up. J. Cardiovasc. Medicine. 2016.17(6):418–424.
García-Niebla J, Baranchuk A, de Luna AB. Epsilon wave in the 12-lead electrocardiogram: is its frequency underestimated? Revista Española de Cardiología. 2016;69(04):438–438.
Gilotra NA, Bhonsale A, James CA, Te Riele ASJ, Murray B, Tichnell C, Sawant A, Ong CS, Judge DP, Russell SD, Calkins H, Tedford RJ. Heart Failure Is Common and Under-Recognized in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy / Dysplasia. Circulation: Heart Failure. 2017;10(9):e003819.
Hauer RN. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmogenesis in the apparently normal heart? Europace: European pacing, arrhythmias, and cardiac electrophysiology: journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2016;18(7):953–954.
Haugaa KH, Basso C, Badano LP, Bucciarelli-Ducci C, Cardim N, Gaemperli O, Galderisi M, Habib G, Knuuti J, Lancellotti P, McKenna W, Neglia D, Popescu BA, Edvardsen T; EACVI Scientific Documents Committee, EACVI Board members and external reviewers; EACVI Scientific Documents Committee, EACVI Board members and external reviewers. Comprehensive multi-modality imaging approach in arrhythmogenic cardiomyopathy-an expert consensus document of the European Association of Cardiovascular Imaging. Eur. Heart J.–Cardiovascular Imaging. 2017;18(3):237–253.
Hsieh WH, Lin CY, Te ALD, Lo MT, Wu CI, Chung FP, Chang YC, Chang SL, Lin C, Lo LW, Hu YF, Liao JN, Chen YY, Jhuo SJ, Raharjo SB, Lin YJ, Chen SA. A novel noninvasive surface ECG analysis using interlead QRS dispersion in arrhythmogenic right ventricular cardiomyopathy. PloS one. 2017;12(8):e0182364.
Indik J.H. Arrhythmic risk stratification for arrhythmogenic right ventricular cardiomyopathy: should we ask who is at high risk or who is at low risk? Circ Arrhythm Electrophysiol 2018;11(2):1–9.
Jurlander R, Mills H, Espersen K.I, Axelsson Raja A, Vejlstrup N, Bundgaard H, Christensen A. Diagnostic yield of cardiovascular magnetic resonance in the screening of relatives to patients with arrhythmogenic right ventricular cardiomyopathy. Eur. Heart J. 2017;38(Suppl. 1):683.
Li KHC, Bazoukis G, Liu T, Li G, Wu WKK, Wong SH, Wong WT, Chan YS, Wong MCS, Wassilew K, Vassiliou VS, Tse G. Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) in clinical practice. J. Arrhythmia. 2017:11–23.
Liao YC, Chung FP, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chao TF, Liao JN, Lin CY, Chang YT, Hsieh MH, Chen SA. The application of signal average ECG in the prediction of recurrences after catheter ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Intern. J. Cardiology. 2017;236:168–173.
Marcus FI. Epsilon waves aid in the prognosis and risk stratification of patients with ARVC/D. J. Cardiovasc. Electrophysiology 2015;26(11):1211–1212.
Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, Calkins H, Corrado D, Cox MG, Daubert JP, Fontaine G, Gear K, Hauer R, Nava A, Picard MH, Protonotarios N, Saffitz JE, Sanborn DM, Steinberg JS, Tandri H, Thiene G, Towbin JA, Tsatsopoulou A, Wichter T, Zareba W. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Eur. Heart J. 2010;31(7):806–814.
Marstrand P, Axelsson A, Thune JJ, Vejlstrup N, Pehrson S, Bundgaard H, Theilade J. Late potentials and their correlation with ventricular structure in patients with ventricular arrhythmias. Pacing Clin. Electrophysiology 2017;40(12):1466–1471.
Masarone D, Kaski JP, Pacileo G, Elliott PM, Bossone E, Day SM, Limongelli G. Epidemiology and clinical aspects of genetic cardiomyopathies. Heart Failure Clinics. 2018;14(2):119–128.
Mast TP, James CA, Calkins H, Teske AJ, Tichnell C, Murray B, Loh P, Russell SD, Velthuis BK, Judge DP, Dooijes D, Tedford RJ, van der Heijden JF, Tandri H, Hauer RN, Abraham TP, Doevendans PA, Te Riele AS, Cramer MJ. Evaluation of structural progression in arrhythmogenic right ventricular dysplasia/cardiomyopathy. JAMA Cardiology. 2017;2(3):293–302.
Maupain C, Waintraub X, Hebert Je-L, Pousset F, Frank R, Duthoit G, Badenco N, Chastre T, Himbert C, Hidden-Lucet F, Gandjbakhch E. Right ventricular dysfunction and epsilon wave: new predicting factors of recurrence of VT after radiofrequency catheter ablation in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Arch. Cardiovascular Diseases Supplements 2016;8(1):73.
McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundqvist C, Fontaine G, Camerini F. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. British Heart J. 1994;71(3):215–218.
Miles C.J., Finocchiaro G., Westaby J.D. et al. Focal arrhythmogenic cardiomyopathy masquerading as RVOT tachycardia: sudden death in a postpartum athlete. Eur. Heart J. 2017;38(Suppl. 1):1429–1430.
Miles CJ, Finocchiaro G, Westaby JD, Papadakis M, Paterson C, Tome M, Sharma S, Behr ER, Curtis S, Sheppard MN. Left ventricular involvement and circumstances of death in arrhythmogenic cardiomyopathy: insights from a large pathology study. Eur. Heart J. 2017;38(Suppl. 1):414.
Moncayo-Arlandi J, Brugada R. Unmasking the molecular link between arrhythmogenic cardiomyopathy and Brugada syndrome. Nature Reviews Cardiology. 2017;14(12):744–756.
Mu J, Zhang G, Xue D, Xi M, Qi J, Dong H. Sudden cardiac death owing to arrhythmogenic right ventricular cardiomyopathy: Two case reports and systematic literature review. Medicine. 2017;96(47):e8808.
Novak J, Zorzi A, Castelletti S, Pantasis A, Rigato I, Corrado D, Mckenna W, Lambiase PD. Electrocardiographic differentiation of idiopathic right ventricular outflow tract ectopy from early arrhythmogenic right ventricular cardiomyopathy. Europace. 2017;19(4):622–628.
Nunes de Alencar Neto J, Baranchuk A, Bayés-Genís A, Bayés de Luna A. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: an electrocardiogram-based review. EP Europace. 2017. eux202
Palmiero G, Carlomagno G, Lucivero G. Diagnosis of cardiomyopathies: tips and tricks for internists and general practitioners. Cardiogenetics. 2017;7(1):6–17.
Parahuleva MS, Figiel J, Ahrens H, Schieffer B, Divchev D, Lüsebrink U. New Task Force Criteria Provide Evolution in Diagnosis of Arrhythmogenic Cardiomyopathy in Patients without Typical Progression of the Disease. Amer. J. Case Reports. 2017;18:299–304.
Pei H, Yu Q, Su X, Wang Z, Zhao H, Yang D, Yang Y, Li D. New Features of Electrocardiogram in a Case Report of Arrhythmogenic Right Ventricular Cardiomyopathy: A Care-Compliant Article. Medicine. 2016;95(16):e3442.
Peters S. Athlete's heart versus arrhythmogenic cardiomyopathy by advanced ECG criteria. Intern. J. Cardiology. 2016;221:654.
Peters S. Diagnosis of arrhythmogenic cardiomyopathy by localized right precordial QRS prolongation and inferior early repolarization phenomenon but without T-wave inversion. Intern. J. Cardiology. 2016;207:97–99.
Peters S. Differentiation between arrhythmogenic cardiomyopathy and early repolarization pattern: A case report with these two entities. Intern. J. Cardiology 2016;215:132–134.
Peters S. Electrocardiographic criteria in founder mutations related to Arrhythmogenic cardiomyopathy. J. Cardiology Cardiovasc. Medicine. 2018;3:005–007.
Peters S. Electrocardiographic morphology in right precordial T waves in arrhythmogenic right ventricular cardiomyopathy. Intern. J. Cardiology. 2016;214:228.
Peters S. Influence Of Novel Electrocardiographic Features Of Provocable Brugada ECG In Arrhythmogenic Cardiomyopathy And Its Exclusion By Lead AVR. J. Atrial Fibrill. 2016;9(1):68–69.
Peters S. Low amplitude ECG and QRS fragmentation in provocable coved-type ST-segment elevation on surface ECG are strong predictors of a continuum between arrhythmogenic cardiomypathy and Brugada syndrome. International journal of cardiology. 2016;214:148–150.
Peters S. Low amplitude of inverted T-waves in lead aVR characterise patients with arrhythmogenic cardiomyopathy. Intern. J. Cardiology 2016;220:201.
Peters S. The correlation between epsilon wave and coved-type ST-segment elevation in a patient with arrhythmogenic cardiomyopathy. Intern. J. Cardiology. 2016;207:230.
Platonov PG, Calkins H, Hauer RN, Corrado D, Svendsen JH, Wichter T, Biernacka EK, Saguner AM, Te Riele AS, Zareba W. High interobserver variability in the assessment of epsilon waves: Implications for diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm 2016;13(1):208–216.
Protonotarios A, Anastasakis A, Tsatsopoulou A, Antoniades L, Prappa E, Syrris P, Tousoulis D, McKENNA WJ, Protonotarios N. Clinical significance of epsilon waves in arrhythmogenic cardiomyopathy. J. Cardiovascular Electrophysiology. 2015;26(11):1204–1210.
Saberniak J, Leren IS, Haland TF, Beitnes JO, Hopp E, Borgquist R, Edvardsen T, Haugaa KH. Comparison of patients with early-phase arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract ventricular tachycardia. Eur. Heart J. Cardiovascular Imaging. 2016;18(1):62–69.
Svensson A, Carlson J, Fluur C, Lundin C, Platonov PG. Low sensitivity of conventional electrocardiographic criteria for arrhythmogenic right ventricular cardiomyopathy at symptom onset: emerging role of inferior T-wave inversion. Eur. Heart J. 2017;38(Suppl. 1):138–146.
Tan AY, Nearing BD, Rosenberg M, Nezafat R, Josephson ME, Verrier RL. Interlead heterogeneity of R‐and T‐wave morphology in standard 12‐lead Ecgs predicts sustained ventricular tachycardia/fibrillation and arrhythmic death in patients with cardiomyopathy. J. Cardiovasc. Electrophysiology. 2017;28(11):1324–1333.
Tanawuttiwat T, Te Riele AS, Philips B, James CA, Murray B, Tichnell C, Sawant AC, Calkins H, Tandri H. Electroanatomic correlates of depolarization abnormalities in arrhythmogenic right ventricular dysplasia/cardiomyopathy. J. Cardiovasc. Electrophysiology. 2016;27(4):443–452.
Tsatsopoulou A., Bossone E. Common presentation of rare diseases: Arrhythmogenic right ventricular cardiomyopathy and its mimics. Intern. J. Cardiology. 2018;257:371–377.
Tschabrunn CM, Haqqani HM, Santangeli P, Erica S, Zado PA-C, Marchlinski FE. Still an Important Tool: 12-Lead electrocardiogram to localize region of abnormal electroanatomic substrate in arrhythmogenic right ventricular cardiomyopathy. JACC: Clinical Electrophysiology. 2017;3(7):654–665.
Yoshihara S, Matsunaga M, Yaegashi T, Suzuki S, Naito M, Takehara Y. Unusual serial electrocardiographic changes which progressed to arrhythmogenic right ventricular cardiomyopathy. Intern. Med. 2016;55(9):1103–1108.